In preliminary studies in T-PLL, CDK9 inhibition decreased the expression of JAK/STAT related transcripts, c-Myc, and Mcl-1 [as has been observed in other hematologic malignancies [91,92]]. This evidence concerns the gene MYC and hematologic disorder.